Skip to main content

GNMSF · Genmab A/S · Investor Relations

Track GNMSF — free
$396.97 At close · Oct 5
Market Cap
$21.72B
Shares
614.90M
Volume · Oct 5 1656 Avg daily vol (3M) 1680

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-05 00:00 UTC Publication of the Interim Report for the First Nine Months 2026 (after 5:00 PM CET) Results publication

Past events

Date Event Type
2026-10-07 Extraordinary General Meeting Shareholder meeting
2026-09-22 Bank of America Global Healthcare Conference Conference
2026-09-15 Morgan Stanley 24th Annual Global Healthcare Conference Conference
2026-09-09 Wells Fargo 21st Annual Healthcare Conference Conference
2026-08-06 Publication of the Interim Report for the First Half 2026 (after 5:00 PM CEST) Earnings call
2026-08-06 Earnings conference call (announced in 6-K) Earnings call
2026-05-07 Publication of the Interim Report for the First Quarter 2026 (after 5:00 PM CEST) Earnings call
2026-03-19 Annual General Meeting 2026 Shareholder meeting
2026-03-11 Barclays 28th Annual Global Healthcare Conference Conference
2026-03-10 Leerink Global Healthcare Conference Conference
2026-03-03 TD Cowen 46th Annual Healthcare Conference Conference
2026-02-17 Publication of the Annual Report for 2025 (after 5:00 PM CET) Webcast
2026-01-13 44th Annual J.P. Morgan Healthcare Conference Conference
2025-12-31 Financial Calendar Year End Event
2025-12-11 2025 R&D Update and ASH Data Review Webcast
2025-12-04 Citi 2025 Global Healthcare Conference Conference
2025-11-19 Jefferies Healthcare Conference Conference
2025-11-06 Publication of the Interim Report for the First Nine Months 2025 (after 5:00 PM CET) Earnings call
2025-09-29 Genmab's Proposed Acquisition of Merus Webcast
2025-09-23 Bank of America 2025 Global Healthcare Conference Conference
2025-09-09 Morgan Stanley 23rd Annual Global Healthcare Conference Conference
2025-08-07 Publication of the Interim Report for the First Half 2025 (after 5:00 PM CEST) Earnings call
2025-06-09 Goldman Sachs 46th Annual Global Healthcare Conference Conference
2025-06-05 2025 Jefferies Global Healthcare Conference Conference
2025-06-02 Post-ASCO R&D Update Webcast

Source: https://ir.genmab.com/

Key facts CIK 1434265 CUSIP 372303206 Visit website Investor relations